RVPH vs. IESC

Last updated Jun 4, 2026

RVPH (Reviva Pharmaceuticals Holdings, Inc.) and IESC (IES Holdings, Inc.) are both stocks. RVPH operates in Biotechnology (Healthcare), while IESC operates in Engineering & Construction (Industrials). Over the past 5 years, RVPH returned -64.08%/yr vs 67.69%/yr for IESC. At a 0.10 correlation, their price movements are largely independent.

Performance

RVPH vs. IESC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Reviva Pharmaceuticals Holdings, Inc. (RVPH) and IES Holdings, Inc. (IESC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RVPH achieves a -89.37% return, which is significantly lower than IESC's 86.22% return.

RVPH

• 1D: -0.29%
• 1M: -29.64%
• YTD: -89.37%
• 6M: -95.01%
• 1Y: -96.36%
• 3Y*: -83.64%
• 5Y*: -64.08%
• 10Y*: —

IESC

• 1D: 2.77%
• 1M: 15.65%
• YTD: 86.22%
• 6M: 72.76%
• 1Y: 166.54%
• 3Y*: 142.30%
• 5Y*: 67.69%
• 10Y*: 47.29%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RVPH vs. IESC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
RVPH Reviva Pharmaceuticals Holdings, Inc.	-89.37%	-84.59%	-64.85%	21.18%	47.06%	-66.95%	-16.40%	6.19%	1.44%
IESC IES Holdings, Inc.	86.22%	93.58%	153.67%	122.72%	-29.76%	9.99%	79.42%	65.02%	-13.32%

Correlation

The correlation between RVPH and IESC is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.18
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.12
Correlation (All Time) Calculated using the full available price history since Oct 19, 2018	0.10

Fundamentals

Market Cap RVPH : $4.17M IESC : $14.62B
EPS RVPH : -$4.74M IESC : $18.85
PB Ratio RVPH : 0.24 IESC : 13.63
Total Revenue (TTM) RVPH : $0.00 IESC : $3.63B
Gross Profit (TTM) RVPH : $0.00 IESC : $931.31M
EBITDA (TTM) RVPH : -$20.20T IESC : $487.14M

Return for Risk

RVPH vs. IESC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RVPH

RVPH Risk / Return Rank: 8
RVPH Sharpe Ratio Rank: 17
RVPH Sortino Ratio Rank: 10
RVPH Omega Ratio Rank: 8
RVPH Calmar Ratio Rank: 2
RVPH Martin Ratio Rank: 5

IESC

IESC Risk / Return Rank: 91
IESC Sharpe Ratio Rank: 93
IESC Sortino Ratio Rank: 86
IESC Omega Ratio Rank: 87
IESC Calmar Ratio Rank: 95
IESC Martin Ratio Rank: 96

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RVPH vs. IESC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Reviva Pharmaceuticals Holdings, Inc. (RVPH) and IES Holdings, Inc. (IESC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RVPH	IESC	Difference
Sharpe ratio: Return per unit of total volatility	-0.56	2.71	-3.27
Sortino ratio: Return per unit of downside risk	-1.14	2.88	-4.02
Omega ratio: Gain probability vs. loss probability	0.83	1.39	-0.56
Calmar ratio: Return relative to maximum drawdown	-0.98	7.69	-8.67
Martin ratio: Return relative to average drawdown	-1.53	21.83	-23.36
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RVPH vs. IESC - Sharpe Ratio Comparison

The current RVPH Sharpe Ratio is -0.56, which is lower than the IESC Sharpe Ratio of 2.71. The chart below compares the historical Sharpe Ratios of RVPH and IESC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	RVPH	IESC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.56	2.71	-3.27
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.50	1.26	-1.76
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.99	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.47	0.05	-0.52

Drawdowns

RVPH vs. IESC - Drawdown Comparison

The maximum RVPH drawdown since its inception was -99.86%, roughly equal to the maximum IESC drawdown of -98.32%. Use the drawdown chart below to compare losses from any high point for RVPH and IESC.

Drawdown Indicators

	RVPH	IESC	Difference
Max Drawdown Largest peak-to-trough decline	-99.86%	-98.32%	-1.54%
Max Drawdown (1Y) Largest decline over 1 year	-98.03%	-21.80%	-76.23%
Max Drawdown (3Y) Largest decline over 3 years	-99.77%	-49.23%	-50.54%
Max Drawdown (5Y) Largest decline over 5 years	-99.81%	-54.28%	-45.53%
Max Drawdown (10Y) Largest decline over 10 years	—	-54.28%	—
Current Drawdown Current decline from peak	-99.75%	0.00%	-99.75%
Average Drawdown Average peak-to-trough decline	-55.48%	-55.03%	-0.45%
Ulcer Index Depth and duration of drawdowns from previous peaks	62.95%	7.66%	+55.29%

Volatility

RVPH vs. IESC - Volatility Comparison

Reviva Pharmaceuticals Holdings, Inc. (RVPH) has a higher volatility of 98.55% compared to IES Holdings, Inc. (IESC) at 12.25%. This indicates that RVPH's price experiences larger fluctuations and is considered to be riskier than IESC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RVPH	IESC	Difference
Volatility (1M) Calculated over the trailing 1-month period	98.55%	12.25%	+86.30%
Volatility (6M) Calculated over the trailing 6-month period	155.29%	49.68%	+105.61%
Volatility (1Y) Calculated over the trailing 1-year period	171.84%	61.92%	+109.92%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	129.33%	53.91%	+75.42%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	114.09%	48.10%	+65.99%

Dividends

RVPH vs. IESC - Dividend Comparison

Neither RVPH nor IESC has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both RVPH and IESC in my portfolio?

RVPH and IESC have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RVPH or IESC?

RVPH has higher volatility (98.55%) compared to IESC (12.25%). In terms of maximum drawdown, RVPH dropped -99.86% vs IESC's -98.32%.

Which has better risk-adjusted returns?

IESC currently has the higher Sharpe Ratio (2.71 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.